SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer - Quaterly Results

11 Aug 2023 Evaluate
Net sales declined -10.38%  to  Rs. 5313.60 million from Rs. 5929.00 millions.The Net Profit of the company reported a remarkable increase of 187.34% to Rs. 935.30  millions  from Rs. 325.50 millions in previous same quarter.Operating Profit reported a sharp decline to 1441.70 millions from 2098.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 5313.60 5929.00 -10.38 5313.60 5929.00 -10.38 24247.60 26109.90 -7.13
Other Income 334.60 180.20 85.68 334.60 180.20 85.68 1010.50 626.50 61.29
PBIDT 1441.70 2098.70 -31.31 1441.70 2098.70 -31.31 9099.10 8983.80 1.28
Interest 28.70 36.40 -21.15 28.70 36.40 -21.15 133.90 104.90 27.65
PBDT 1413.00 699.00 102.15 1413.00 699.00 102.15 9295.20 8878.90 4.69
Depreciation 155.50 265.10 -41.34 155.50 265.10 -41.34 1055.10 1150.00 -8.25
PBT 1257.50 433.90 189.81 1257.50 433.90 189.81 8240.10 7728.90 6.61
TAX 322.20 108.40 197.23 322.20 108.40 197.23 2000.80 1603.30 24.79
Deferred Tax -12.10 -154.10 -92.15 -12.10 -154.10 -92.15 -519.10 -359.30 44.48
PAT 935.30 325.50 187.34 935.30 325.50 187.34 6239.30 6125.60 1.86
Equity 457.50 457.50 0.00 457.50 457.50 0.00 457.50 457.50 0.00
PBIDTM(%) 27.13 35.40 -23.35 27.13 35.40 -23.35 37.53 34.41 9.06

Pfizer Share Price

4815.00 3.95 (0.08%)
11-May-2026 09:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.00
Dr. Reddys Lab 1281.55
Cipla 1339.50
Zydus Lifesciences 932.80
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×